Navigation Links
Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
Date:1/7/2011

as CMV, herpes simplex virus and Epstein Barr virus, polyoma viruses such as BK virus and JC virus, and pox viruses.

Over 325 people have received CMX001 to date, including over 130 patients treated under Emergency INDs.  CMX001 has been well tolerated in all studies, with a growing body of evidence of the compound's antiviral activity in humans.  CMX001 is also being developed as a medical countermeasure in the event of a smallpox outbreak.  Chimerix has received significant funding from the National Institute of Allergy and Infectious Disease to develop CMX001 for smallpox.

Chimerix's second clinical-stage antiviral compound CMX157, a potent nucleoside analogue with activity against HIV and hepatitis B, is in development for the treatment of HIV infection including those caused by multi-drug resistant viruses.  CMX157 has completed Phase 1 clinical studies demonstrating that the compound is well tolerated and that the active antiviral, TFV-PP, was measurable in peripheral blood mononuclear cells (PBMCs) after a single dose and remained detectable for six days, suggesting the possibility of a convenient, once-weekly dosing regimen. CMX157's promising safety profile and efficient conversion to the active drug in PBMCs, coupled with the potent in vitro antiviral activity across diverse drug-resistant strains of HIV, indicate that this compound may directly address several limitations of current HIV therapies.

Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, malaria and other global public health needs.  For additional information on Chimerix, please visit http://www.chimerix.com.

(1) Code of Federal Regulations, Title 21, Revised April 2010


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
6. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
7. Chimerix to Present at 9th Annual BIO Investor Forum
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)...  Tokyo-based Atonarp Inc. announced today $8 million ... Walden Riverwood Ventures with participation from other co-investors.  ... Spectrometer technology platform, which will enable a broad ... oil & gas and healthcare industries for its ... partner with Atonarp in pursuing the commercialization of ...
(Date:8/19/2014)... 2014  AVIA – a provider-led accelerator that puts ... problems in healthcare ­– announces Sutter Health, a not-for-profit ... as the most recent addition to the AVIA Innovator ... AVIA,s inaugural cohort focused helping patients navigate the healthcare ... a patient,s providers so they work as a larger ...
(Date:8/19/2014)... , Aug. 19, 2014 According to ... component needed to make Big Data in healthcare a ... sales.  As part of the American Recovery and Reinvestment ... medical record (EMR) projects and penalties will start applying ... Kalorama Information, in its complete study of the EMR ...
Breaking Medicine Technology:Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2AVIA and Sutter Health Join Forces to Address Healthcare's Most Pressing Challenges 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... Horizon Blue Cross Blue Shield of New Jersey (Horizon ... teaming up during The Barclays at The Ridgewood County ... and Horizon BCBSNJ will be getting spectators into the walking ... own. , Horizon BCBSNJ, the official health care sponsor of ... to the New Jersey Golf Foundation, an organization that removes ...
(Date:8/19/2014)... News) -- Lupus and other rheumatic diseases can ... which can delay a correct diagnosis for months, ... diseases can also cause these types of symptoms, ... in Maywood, Ill. Rheumatic disorders include autoimmune ... tissues, such as lupus, systemic vasculitis and ankylosing ...
(Date:8/19/2014)... Grande Naturals, LLC is proud ... the 2014 Independent Cosmetics Manufacturers & Distributors Award ... position in “Product Innovation; Product Color Cosmetic” for ... includes a lash enhancement serum, GrandeLINER™. GrandeLINER™ ... , This all-new eyeliner is a ...
(Date:8/19/2014)... Merrick, NY (PRWEB) August 19, 2014 In honor ... helping you care for your old furry friend by offering tips ... to rely on their owners more. Because of this, dog owners ... for them. , As dogs age, their needs change. They will ... outside as much as they used to. Because of this, pet ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 Following the completion ... Grand Hyatt Tampa Bay is proud to debut the ... second project included a full revamp of all public spaces ... guest rooms and suites, an all-new dining experience at 1823 ... hotel lobby. , With the introduction of 1823 Kitchen and ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 2Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 3Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 4Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2
... park is more than just a nice way to ... health, according to University of Illinois environment and behavior ... advocates, landscape architects, and popular writers have consistently claimed ... recently, their claims haven,t undergone rigorous scientific assessment." ...
... California, San Diego School of Medicine say antibodies to ... be useful as a future biomarker for predicting cancer ... concentration, used as a treatment for suppressing tumor growth. ... MD, assistant clinical professor of medicine, and Ajit Varki, ...
... News) -- Motorcycle deaths in the United States fell by about ... row fatalities have declined, according to a new report. The ... accidents in 2010 than in 2009, according to a report released ... estimated 4,465 were killed in 2009 compared to 4,376 in 2010. ...
... prohibition against testosterone therapy in men with untreated or ... study published in The Journal of Urology . ... a history of prostate cancer, even if treated and ... to the belief that testosterone activated prostate cancer growth, ...
... Translational Behavioral Medicine: Practice, Policy, Research (TBM), ... The journal will debut with a special section, ... Behavioral Medicine is an international, peer-reviewed journal ... is to engage, inform, and catalyze dialogue among ...
... study published in The American Journal on Addictions ... have high rates of substance use disorders. , Led by ... used national administrative data from the Department of Veterans Affairs ... served in Iraq and Afghanistan who were also diagnosed with ...
Cached Medicine News:Health News:Green environments essential for human health 2Health News:Green environments essential for human health 3Health News:Green environments essential for human health 4Health News:A cancer marker and treatment in 1? 2Health News:A cancer marker and treatment in 1? 3Health News:Motorcycle Deaths Drop for Second Straight Year: Report 2Health News:Study suggests another look at testosterone-prostate cancer link 2Health News:Study suggests another look at testosterone-prostate cancer link 3Health News:Springer launches new journal, Translational Behavioral Medicine: Practice, Policy, Research 2
... Radianse indoor positioning supports patient ... length-of-stay. Ensure the right patients are ... right procedures. Respond to the exact ... or a monitor alarms. Measure patient ...
MONOJECT MAGELLAN Safety Blood Collection Needle...
... Eclipse Blood Collection Needle consists of a ... a safety shield aligned to the bevel-up ... Vacutainer Eclipse Blood Collection Needle has its ... to attach a secondary safety accessory. Immediate, ...
... Shielding Blood Collection Needle is designed ... protection against needlesticks during a blood ... automatically upon insertion of the first ... the first tube is inserted through ...
Medicine Products: